Oxford Immunotec Global Mergers and Acquisitions Summary

Medical Products Company

Oxford Immunotec Global has acquired 3 companies, including 2 in the last 5 years.

Oxford Immunotec Global’s largest acquisition to date was in 2016, when it acquired Imugen for $22M. Oxford Immunotec Global has acquired in 2 different US states. The Company’s most targeted sectors include life science (34%) and medical products (34%).

Join Mergr and gain access to Oxford Immunotec Global’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the medical products sector.

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity3
  • Total Sectors Invested 3
  • Total Countries Invested 1

Oxford Immunotec Global PLC

143 Park Drive Milton Park,
Abingdon, OX14 4SE
United Kingdom,
+44 1235 442780
www.oxfordimmunotec.com

Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of immune-regulated conditions. The Company’s first product is the T-SPOT.TB test, which is used to test for tuberculosis infection. The T-SPOT.TB test has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China. The T-SPOT.CMV test and the T-SPOT.PRT test are the Company’s second and third products and part of a series of products intended for the transplantation market. In addition to these three products, the Company has an additional six active development programs, each of which leverages our T cell, B cell and innate immune measuring technology. Oxford Immunotec Global was founded in 2002 and is based in Abingdon, the United Kingdom.


M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (0.4/yr) # 1 2 - - - - 3
vol $8M $28M $36M
Sell (0.0/yr) # - - - - - - 0
  3

Most Recent M&A

Company Date Value Type
Immunetics, Inc. 2016-10-12 6M USD Add-on Acquisition
Boston, Massachusetts · www.immunetics.com
Imugen, Inc. 2016-06-23 22M USD Add-on Acquisition
Norwood, Massachusetts · www.imugen.com
Boulder Diagnostics, Inc. 2014-08-05 8M USD Add-on Acquisition
Boulder, Colorado · www.oxfordimmunotec.com/north-america/boulder-diagnostics
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (33%) 6M (17%) - -
Medical Products 1 (33%) 8M (22%) - -
Test/Measurement Equipment 1 (33%) 22M (61%) - -
Total 3 $36M - -

By Geo

State/Country Buy Value Sell Value
United States 3 36M - -
  Massachusetts 2 28M - -
  Colorado 1 8M - -
Total 3 $36M - -

Deal Values

buy # Total
< $100M 3 $36M
TOTAL $36M
Largest Imugen, Inc.
$22M (2016-06-23)

 Subscribe to unlock this and 148,764
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.8K Private Equity Firms
  • 136K M&A Transactions
  • 145K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.0K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.